论文部分内容阅读
目的探讨手足口病50例临床治疗分析。方法选取该院2015年6月—2016年6月门诊治疗的患有手足口病的100例患儿进行回顾性分析,将其按照就诊顺序分为两组,对照组50例患儿采用的是常规治疗,观察组50例患儿在常规治疗基础上加上α-1b干扰素雾化治疗,对两组患儿的临床症状进行观察。结果治疗后,两组患者的治疗总有效率分别为98.0%、82.0%,存在较大差异性和统计学意义;两组患儿出现不良反应发生率分别为6.0%、16.0%,差异有统计学意义(P<0.05)。结论手足口病采用α-1b干扰素雾化治疗的临床效果较为显著,可以改善患儿的临床症状,显著优于单一使用常规治疗的疗效,可在临床治疗中推广应用。
Objective To investigate the clinical treatment of 50 cases of hand, foot and mouth disease. Methods A total of 100 children with HFMD in our hospital from June 2015 to June 2016 were retrospectively analyzed. They were divided into two groups according to the order of treatment. Fifty children in the control group were Conventional treatment, observation group of 50 patients on the basis of conventional therapy plus α-1b interferon nebulization therapy, the clinical symptoms of two groups were observed. Results After treatment, the total effective rates of the two groups were 98.0% and 82.0%, respectively, with significant differences and statistical significance. The incidence of adverse reactions in both groups were 6.0% and 16.0%, respectively, with statistical differences Significance (P <0.05). Conclusion The clinical effect of α-1b interferon nebulization for hand-foot-mouth disease is more significant, which can improve the clinical symptoms of children and is significantly better than that of conventional treatment. It can be widely used in clinical treatment.